Evidence map›Paper›PMID 30496256›Full record

ArticlePloS one2018

Agnostic detection of genomic alterations by holistic DNA structural interrogation.

Ryan K Shultzaberger, Rachel E Abrams, Challise J Sullivan, Anthony D Schmitt, Thomas W J Thompson, John Dresios

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryan K ShultzabergerLeidos, Inc., San Diego, CA, United States of America.ORCID 0000-0002-4586-0659
Rachel E AbramsLeidos, Inc., San Diego, CA, United States of America.
Challise J SullivanLeidos, Inc., San Diego, CA, United States of America.ORCID 0000-0001-6467-5670
Anthony D SchmittArima Genomics Inc., San Diego, CA, United States of America.
Thomas W J ThompsonLeidos, Inc., San Diego, CA, United States of America.ORCID 0000-0001-6227-7986
John DresiosLeidos, Inc., San Diego, CA, United States of America.ORCID 0000-0001-5192-1588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an established relationship between primary DNA sequence, secondary and tertiary chromatin structure, and transcriptional activity, suggesting that observed differences in one of these properties may reflect changes in the others. Here, we exploit these relationships to show that variations in DNA structure can be used to identify a wide range of genomic alterations in mammalian samples. In this proof-of-concept study we characterized and compared genome-wide histone occupancy by ChIP-Seq, DNA accessibility by ATAC-Seq, and chromosomal conformation by Hi-C for five CRISPR/Cas9-modified mammalian cell lines and their unmodified parent strains, as well as in one modified tissue sample and its parent strain. The results showed that the impact of genomic alterations on each of the levels of DNA organization varied depending on mutation type (insertion or deletion), size, and genomic location. The largest genomic alterations we identified included chromosomal rearrangements and deletions (greater than 200 Kb) in four of the modified cell lines, which can be difficult to identify by standard whole genome sequencing analysis. This multi-level DNA organizational analysis provides a sensitive approach for identifying a wide range of genomic and epigenomic perturbations that can be utilized for biomedical and biosecurity applications.

Indexed as

ChromatinChromatin ImmunoprecipitationDNAEpigenomicsGene Expression RegulationGenome, HumanGenomicsHigh-Throughput Nucleotide SequencingHistonesHumansMutationProof of Concept StudySequence Analysis, DNAStructure-Activity RelationshipChromatinDNAHistones

Identifiers

PMID30496256
PMCPMC6264503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.